Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» restructuring
restructuring
2Seventy CEO Leschly to step down as company cuts staff, spending
2Seventy CEO Leschly to step down as company cuts staff, spending
BioPharma Dive
2seventy bio
restructuring
layoffs
Nick Leschly
Flag link:
Apellis to lay off 25% of staff, trim research in major restructuring
Apellis to lay off 25% of staff, trim research in major restructuring
BioPharma Dive
Apellis Pharmaceuticals
restructuring
layoffs
Flag link:
Biogen kicks off 1,000 layoffs as part of CEO Viehbacher’s ‘complete redesign’
Biogen kicks off 1,000 layoffs as part of CEO Viehbacher’s ‘complete redesign’
Fierce Pharma
Biogen
layoffs
restructuring
Flag link:
CVS Health Profits Drop To $1.9 Billion As Restructuring Costs Take Hold
CVS Health Profits Drop To $1.9 Billion As Restructuring Costs Take Hold
Forbes
CVS Health
earnings
restructuring
Flag link:
Amarin axes 120 of its 385 employees, hires new CEO Patrick Holt
Amarin axes 120 of its 385 employees, hires new CEO Patrick Holt
Fierce Pharma
Amarin
layoffs
restructuring
Patrick Holt
Flag link:
J&J records $130M restructuring expense in Q1 overhaul of infectious disease unit
J&J records $130M restructuring expense in Q1 overhaul of infectious disease unit
Fierce Biotech
JNJ
Janssen
earnings
restructuring
infectious disease
Flag link:
Amid major restructuring, Novartis CEO Narasimhan’s 2022 pay fell by more than a quarter
Amid major restructuring, Novartis CEO Narasimhan’s 2022 pay fell by more than a quarter
Fierce Pharma
Novartis
Pharma CEOs
Vas Narasimhan
executive pay
restructuring
Flag link:
Talaris Slashes Workforce, Shifts Focus in Restructuring
Talaris Slashes Workforce, Shifts Focus in Restructuring
BioSpace
Talaris Therapeutics
layoffs
restructuring
FCR001
kidney transplant
Flag link:
Bayer's 3 business units 'perfectly positioned,' trade union says in resistance to potential breakup
Bayer's 3 business units 'perfectly positioned,' trade union says in resistance to potential breakup
Fierce Pharma
Bayer
Roche
Werner Baumann
restructuring
Flag link:
Diagnostics companies turn to restructuring in bid to preserve cash: Goldman
Diagnostics companies turn to restructuring in bid to preserve cash: Goldman
Medtech Dive
diagnostics
restructuring
Cue Health
GeneDx
Invitae
EXACT Sciences
Guardant Health
Flag link:
Medtronic’s Chan talks patient monitoring spinoff, rise of home care
Medtronic’s Chan talks patient monitoring spinoff, rise of home care
Medtech Dive
Medtronic
Medtech
patient monitoring
spinoffs
restructuring
Flag link:
J&J's pharma group quietly works through global overhaul, with layoffs expected to reach multiple countries
J&J's pharma group quietly works through global overhaul, with layoffs expected to reach multiple countries
Fierce Pharma
JNJ
layoffs
restructuring
Flag link:
5 questions facing emerging biotech in 2023
5 questions facing emerging biotech in 2023
BioPharma Dive
biotech
IPOs
platform companies
funding
restructuring
Inflation Reduction Act
Flag link:
Novartis sells U.S. rights to five drugs to Harrow for up to $175M
Novartis sells U.S. rights to five drugs to Harrow for up to $175M
Medical Marketing and Media
Novartis
eye health
restructuring
Harrow Health
Flag link:
Months after slimming its R&D focus, Orion realigns stars in top-down organizational restructure
Months after slimming its R&D focus, Orion realigns stars in top-down organizational restructure
Fierce Biotech
Orion
restructuring
layoffs
R&D
Finland
Flag link:
Novartis to lay off 400 at Dublin campus amid global restructuring
Novartis to lay off 400 at Dublin campus amid global restructuring
Fierce Pharma
Novartis
Ireland
layoffs
restructuring
Flag link:
Another biotech grabs the axe, chopping R&D in a major reorganization as drug sales disappoint
Another biotech grabs the axe, chopping R&D in a major reorganization as drug sales disappoint
Endpoints
Heron Therapeutics
R&D
layoffs
restructuring
Flag link:
Novartis Reveals Restructure will Cost up to 8,000 Jobs
Novartis Reveals Restructure will Cost up to 8,000 Jobs
BioSpace
Novartis
restructuring
layoffs
Flag link:
Amarin turns to job cuts as generics challenge its heart pill
Amarin turns to job cuts as generics challenge its heart pill
BioPharma Dive
Amarin
Vascepa
restructuring
layoffs
Flag link:
Praxis wields the axe as lead depression drug fails
Praxis wields the axe as lead depression drug fails
Pharmaforum
Praxis Precision Medicines
major depressive disorder
layoffs
restructuring
PRAX-114
Flag link:
Pages
1
2
3
4
5
6
7
8
9
next ›
last »